Drug-induced long QT and torsade de pointes: recent advances

Schwartz, 2006, The congenital long QT syndromes from genotype to phenotype: clinical implications, J Intern Med, 259, 39, 10.1111/j.1365-2796.2005.01583.x

Roden, 2005, Genetics of acquired long QT syndrome, J Clin Invest, 115, 2025, 10.1172/JCI25539

Curran, 1995, A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome, Cell, 80, 795, 10.1016/0092-8674(95)90358-5

Sanguinetti, 2006, hERG potassium channels and cardiac arrhythmia, Nature, 440, 463, 10.1038/nature04710

Fernandez, 2004, Physicochemical features of the HERG channel drug binding site, J Biol Chem, 279, 10120, 10.1074/jbc.M310683200

Cordes, 2005, Pentamidine reduces hERG expression to prolong the QT interval, Br J Pharmacol, 145, 15, 10.1038/sj.bjp.0706140

Kuryshev, 2005, Pentamidine-induced long QT syndrome and block of hERG trafficking, J Pharmacol Exp Ther, 312, 316, 10.1124/jpet.104.073692

Anderson, 2006, Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism, Circulation, 113, 365, 10.1161/CIRCULATIONAHA.105.570200

Rajamani, 2002, Pharmacological rescue of human K(+) channel long-QT2 mutations: human ether-a-go-go-related gene rescue without block, Circulation, 105, 2830, 10.1161/01.CIR.0000019513.50928.74

Liu, 2005, New mechanism contributing to drug-induced arrhythmia: rescue of a misprocessed LQT3 mutant, Circulation, 112, 3239, 10.1161/CIRCULATIONAHA.105.564008

Lazzara, 1989, Amiodarone and torsade de pointes, Ann Intern Med, 111, 549, 10.7326/0003-4819-111-7-549

Antzelevitch, 2005, Role of transmural dispersion of repolarization in the genesis of drug-induced torsades de pointes, Heart Rhythm, 2, S9, 10.1016/j.hrthm.2004.09.011

Xia, 2005, In vivo validation of the coincidence of the peak and end of the T wave with full repolarization of the epicardium and endocardium in swine, Heart Rhythm, 2, 162, 10.1016/j.hrthm.2004.11.011

Yamaguchi, 2003, T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity, Clin Sci (Lond), 105, 671, 10.1042/CS20030010

Grabowski, 2004, Images in cardiovascular medicine: drug-induced long-QT syndrome with macroscopic T-wave alternans, Circulation, 110, e459, 10.1161/01.CIR.0000147541.49575.15

Shimizu, 1999, Cellular and ionic basis for T-wave alternans under long-QT conditions, Circulation, 99, 1499, 10.1161/01.CIR.99.11.1499

Thomsen, 2004, Increased short-term variability of repolarization predicts d-sotalol-induced torsades de pointes in dogs, Circulation, 110, 2453, 10.1161/01.CIR.0000145162.64183.C8

Zhang, 1999, Mechanism of block and identification of the verapamil binding domain to HERG potassium channels, Circ Res, 84, 989, 10.1161/01.RES.84.9.989

Shimizu, 1995, Effects of verapamil and propranolol on early afterdepolarizations and ventricular arrhythmias induced by epinephrine in congenital long QT syndrome, J Am Coll Cardiol, 26, 1299, 10.1016/0735-1097(95)00313-4

Aiba, 2005, Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil, J Am Coll Cardiol, 45, 300, 10.1016/j.jacc.2004.09.069

Lu, 2006, Calmodulin antagonist W-7 prevents sparfloxacin-induced early afterdepolarizations (EADs) in isolated rabbit purkinje fibers: importance of beat-to-beat instability of the repolarization, J Cardiovasc Electrophysiol, 17, 415, 10.1111/j.1540-8167.2006.00420.x

Roden, 1986, Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care, Am Heart J, 111, 1088, 10.1016/0002-8703(86)90010-4

Makkar, 1993, Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs, JAMA, 270, 2590, 10.1001/jama.1993.03510210076031

Zareba, 2003, Modulating effects of age and gender on the clinical course of long QT syndrome by genotype, J Am Coll Cardiol, 42, 103, 10.1016/S0735-1097(03)00554-0

Rautaharju, 1992, Sex differences in the evolution of the electrocardiographic QT interval with age, Can J Cardiol, 8, 690

Arya, 2005, Gender-related differences in ventricular repolarization: beyond gonadal steroids, J Cardiovasc Electrophysiol, 16, 525, 10.1111/j.1540-8167.2005.40845.x

Liu, 2005, Sex modulates the arrhythmogenic substrate in prepubertal rabbit hearts with Long QT 2, J Cardiovasc Electrophysiol, 16, 516, 10.1046/j.1540-8167.2005.40622.x

Yang, 1997, Rapid inactivation determines the rectification and [K+]o dependence of the rapid component of the delayed rectifier K+ current in cardiac cells, Circ Res, 80, 782, 10.1161/01.RES.80.6.782

Numaguchi, 2000, A sensitive mechanism for cation modulation of potassium current, Nat Neurosci, 3, 429, 10.1038/74793

Yang, 1996, Extracellular potassium modulation of drug block of IKr: implications for torsade de pointes and reverse use-dependence, Circulation, 93, 407, 10.1161/01.CIR.93.3.407

Etheridge, 2003, A new oral therapy for long QT syndrome: long-term oral potassium improves repolarization in patients with HERG mutations, J Am Coll Cardiol, 42, 1777, 10.1016/j.jacc.2003.07.006

Choy, 1997, Normalization of acquired QT prolongation in humans by intravenous potassium, Circulation, 96, 2149, 10.1161/01.CIR.96.7.2149

Kay, 1983, Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients, J Am Coll Cardiol, 2, 806, 10.1016/S0735-1097(83)80226-5

Choy, 1999, Exaggerated QT prolongation after cardioversion of atrial fibrillation, J Am Coll Cardiol, 34, 396, 10.1016/S0735-1097(99)00226-0

Darbar, 2004, Marked steepening of QT restitution following cardioversion of atrial fibrillation [abstract], Heart Rhythm, 1, S192

McCray, 2006, Persistent atrial fibrillation is associated with reduced risk of torsades de pointes in patients with drug-induced long QT syndrome [abstract], Heart Rhythm, 3, S114, 10.1016/j.hrthm.2006.02.345

Morissette, 2005, Drug-induced long QT syndrome and torsade de pointes, Can J Cardiol, 21, 857

Honig, 1992, Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin, Clin Pharmacol Ther, 52, 231, 10.1038/clpt.1992.135

Ray, 2004, Oral erythromycin and the risk of sudden death from cardiac causes, N Engl J Med, 351, 1089, 10.1056/NEJMoa040582

Kannankeril, 2005, Genetic susceptibility to acquired long QT syndrome: pharmacologic challenge in first-degree relatives, Heart Rhythm, 2, 134, 10.1016/j.hrthm.2004.10.039

Yang, 2002, Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes, Circulation, 105, 1943, 10.1161/01.CIR.0000014448.19052.4C

Roden, 2006, Long QT syndrome: reduced repolarization reserve and the genetic link, J Intern Med, 259, 59, 10.1111/j.1365-2796.2005.01589.x